Miljanovic Danijela, Milicevic Ognjen, Loncar Ana, Abazovic Dzihan, Despot Dragana, Banko Ana
Virology Laboratory, Faculty of Medicine, Institute of Microbiology and Immunology, University of Belgrade, Belgrade, Serbia.
Faculty of Medicine, Institute for Medical Statistics and Informatics, University of Belgrade, Belgrade, Serbia.
Front Microbiol. 2021 Jun 18;12:691154. doi: 10.3389/fmicb.2021.691154. eCollection 2021.
March 6, 2020 is considered as the official date of the beginning of the COVID-19 epidemic in Serbia. In late spring and early summer 2020, Europe recorded a decline in the rate of SARS-CoV-2 infection and subsiding of the first wave. This trend lasted until the fall, when the second wave of the epidemic began to appear. Unlike the rest of Europe, Serbia was hit by the second wave of the epidemic a few months earlier. Already in June 2020, newly confirmed cases had risen exponentially. As the COVID-19 pandemic is the first pandemic in which there has been instant sharing of genomic information on isolates around the world, the aim of this study was to analyze whole SARS-CoV-2 viral genomes from Serbia, to identify circulating variants/clade/lineages, and to explore site-specific mutational patterns in the unique early second wave of the European epidemic. This analysis of Serbian isolates represents the first publication from Balkan countries, which demonstrates the importance of specificities of local transmission especially when preventive measures differ among countries. One hundred forty-eight different genome variants among 41 Serbian isolates were detected in this study. One unique and seven extremely rare mutations were identified, with locally specific continuous dominance of the 20D clade. At the same time, amino acid substitutions of newly identified variants of concern were found in our isolates from October 2020. Future research should be focused on functional characterization of novel mutations in order to understand the exact role of these variations.
2020年3月6日被视为塞尔维亚新冠疫情开始的官方日期。2020年春末夏初,欧洲记录到严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染率下降,第一波疫情消退。这一趋势持续到秋季,此时第二波疫情开始出现。与欧洲其他地区不同,塞尔维亚几个月前就受到了第二波疫情的冲击。早在2020年6月,新确诊病例就呈指数级上升。由于新冠大流行是第一例在全球范围内即时共享分离株基因组信息的大流行,本研究的目的是分析来自塞尔维亚的完整SARS-CoV-2病毒基因组,识别流行的变异株/进化枝/谱系,并探索欧洲疫情独特的早期第二波中特定位点的突变模式。对塞尔维亚分离株的这一分析代表了巴尔干国家的首次发表,证明了本地传播特异性的重要性,尤其是当各国的预防措施不同时。本研究在41株塞尔维亚分离株中检测到148种不同的基因组变异。鉴定出1个独特突变和7个极其罕见的突变,20D进化枝在当地具有特异性持续优势。同时,在我们2020年10月的分离株中发现了新确定的关注变异株的氨基酸替换。未来的研究应集中在新突变的功能表征上,以了解这些变异的确切作用。